US 11603407
Stable antibody formulation
granted A61KA61K47/183A61K47/26
Quick answer
US patent 11603407 (Stable antibody formulation) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K47/183, A61K47/26, A61K9/0019